Overview
- 236 inspections across 191 sites are on record.
- 331 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-01.
At a glance
Inspections
236
Sites
191
Observations
331
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| PPD Development, L.P. | 1 May 2026 | Biologics | |
| Viant Holdings, LLC | 20 Mar 2026 | Biologics | |
| Charles River Laboratories Ireland Ltd. | 6 Feb 2026 | Biologics | |
| SGS Institut Fresenius GmbH | 2 Feb 2026 | Biologics | |
| Novartis Pharmaceutical Manufacturing GmbH | 27 Jan 2026 | Biologics |
Sites inspected
PPD Development, L.P.Middleton, United States1 insp.
Viant Holdings, LLCLaconia, United States1 insp.
Charles River Laboratories Ireland Ltd.Ballina, Ireland1 insp.
SGS Institut Fresenius GmbHTaunusstein, Germany1 insp.
Novartis Pharmaceutical Manufacturing GmbHKundl, Austria1 insp.
Co-investigators
Investigators who share inspections with this person.
Linda Thai7 shared
Mihaly S Ligmond7 shared
Lewis K Antwi6 shared
Laurel A Beer6 shared
Scott T Ballard6 shared
Brentley S Collins5 shared
Meihong Liu5 shared
Omotunde O Osunsanmi4 shared
Ka L Wong4 shared
Arsen Karapetyan4 shared
Full investigator report
Get the verbatim findings behind Gene D Arcy's 331 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site